Xenon Pharmaceuticals

XENE

Capitalización de mercado USD 4008 M

#	Nombre	Posición	Valor operado	Cambio en acciones	Cambio en la participación
1	1 BVF Inc San Francisco, California	USD 10.5 M	–	–	–
2	2 Capital World Investors Los Angeles, California	USD 6.1 M	–	–	–
3	3 Invesco Private Capital New York	USD 2.58 M	–	–	–
4	4 Perceptive Advisors New York	USD 2.55 M	+USD 1.56 M	+227,000	+110%
5	OM 5 Opaleye Management Boston, Massachusetts	USD 2.42 M	+USD 68.6 k	+10,000	+3%
6	6 Royal Bank of Canada Toronto, Ontario, Canada	USD 2.32 M	-USD 518 k	-75,519	-16%
7	7 Point72 Asset Management Stamford, Connecticut	USD 2.12 M	–	–	–
8	8 DAFNA Capital Management Los Angeles, California	USD 1.26 M	+USD 143 k	+20,896	+11%
9	9 Novo Holdings A/S Hellerup, Denmark	USD 753 k	–	–	–
10	10 State of New Jersey Common Pension Fund D Trenton, New Jersey	USD 385 k	–	–	–
11	11 Leith Wheeler Investment Counsel Vancouver, British Columbia, Canada	USD 370 k	+USD 12.3 k	+1,794	+11%
12	12 Renaissance Technologies New York	USD 286 k	+USD 101 k	+14,700	+43%
13	13 Weiss Multi-Strategy Advisers New York	USD 191 k	-USD 128 k	-18,600	-36%
14	14 NJ State Employees Deferred Compensation Plan Trenton, New Jersey	USD 118 k	–	–	–
15	15 Bank of Montreal Toronto, Ontario, Canada	USD 42 k	–	–	–
16	16 Deutsche Bank Frankfurt Am Main Ge, Germany	USD 21 k	-USD 27.2 k	-3,970	-52%
17	17 Wells Fargo San Francisco, California	USD 17 k	-USD 13.7 k	-2,000	-41%
18	18 Tower Research Capital (TRC) New York	USD 6 k	-USD 10 k	-1,458	-62%
19	19 Morgan Stanley New York	USD 5 k	–	–	–
20	20 Citigroup New York	USD 4 k	–	–	–
21	21 JP Morgan Chase New York	USD 1 k	+USD 761	+111	Nuevas
22	22 Visium Asset Management New York	–	-USD 2.94 M	-420,000	Cerradas
23	JC 23 JBF Capital Aspen, Colorado	–	-USD 480 k	-68,690	Cerradas
24	24 GSA Capital Partners London, United Kingdom	–	-USD 94 k	-13,384	Cerradas
25	25 UBS Group Zurich, Switzerland	–	-USD 8 k	-1,106	Cerradas

Xenon Pharmaceuticals XENE Capitalización de mercado USD 4008 M

Xenon Pharmaceuticals

XENE

Capitalización de mercado USD 4008 M